vs
Side-by-side financial comparison of Global Medical REIT Inc. (GMRE) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $38.4M, roughly 1.2× Global Medical REIT Inc.). Global Medical REIT Inc. runs the higher net margin — -16.0% vs -33.9%, a 17.9% gap on every dollar of revenue. On growth, Global Medical REIT Inc. posted the faster year-over-year revenue change (9.2% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 4.6%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
GMRE vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.4M | $47.1M |
| Net Profit | $-6.1M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | — | -17.7% |
| Net Margin | -16.0% | -33.9% |
| Revenue YoY | 9.2% | -15.6% |
| Net Profit YoY | -309.2% | 68.8% |
| EPS (diluted) | $-0.48 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.4M | $47.1M | ||
| Q3 25 | $37.2M | $38.2M | ||
| Q2 25 | $38.0M | $38.4M | ||
| Q1 25 | $34.6M | $32.5M | ||
| Q4 24 | $35.2M | $55.8M | ||
| Q3 24 | $34.3M | $29.3M | ||
| Q2 24 | $34.2M | $34.0M | ||
| Q1 24 | $35.1M | $25.5M |
| Q4 25 | $-6.1M | $-16.0M | ||
| Q3 25 | $-5.1M | $-23.8M | ||
| Q2 25 | $585.0K | $202.5M | ||
| Q1 25 | $3.7M | $-25.0M | ||
| Q4 24 | $2.9M | $-51.1M | ||
| Q3 24 | $3.4M | $-148.3M | ||
| Q2 24 | $-2.0M | $-582.3M | ||
| Q1 24 | $2.3M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | — | -17.7% | ||
| Q3 25 | — | -33.6% | ||
| Q2 25 | — | -34.8% | ||
| Q1 25 | — | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | — | -493.2% | ||
| Q2 24 | — | -1705.5% | ||
| Q1 24 | — | -267.0% |
| Q4 25 | -16.0% | -33.9% | ||
| Q3 25 | -13.6% | -62.2% | ||
| Q2 25 | 1.5% | 527.8% | ||
| Q1 25 | 10.8% | -76.9% | ||
| Q4 24 | 8.4% | -91.6% | ||
| Q3 24 | 9.9% | -506.3% | ||
| Q2 24 | -5.7% | -1712.6% | ||
| Q1 24 | 6.6% | -283.9% |
| Q4 25 | $-0.48 | $-4.40 | ||
| Q3 25 | $-0.45 | $-2.84 | ||
| Q2 25 | $-0.01 | $-1.79 | ||
| Q1 25 | $0.03 | $-0.15 | ||
| Q4 24 | $-0.04 | $-15.29 | ||
| Q3 24 | $0.14 | $-18.24 | ||
| Q2 24 | $-0.05 | $-71.81 | ||
| Q1 24 | $0.01 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.1M | $48.9M |
| Total DebtLower is stronger | $1.2M | — |
| Stockholders' EquityBook value | $509.8M | $-249.4M |
| Total Assets | $1.2B | $308.9M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.1M | $48.9M | ||
| Q3 25 | $7.1M | $43.1M | ||
| Q2 25 | $6.6M | $40.8M | ||
| Q1 25 | $5.4M | $58.6M | ||
| Q4 24 | $6.8M | $56.3M | ||
| Q3 24 | $5.7M | $75.4M | ||
| Q2 24 | $5.0M | $89.6M | ||
| Q1 24 | $1.3M | $112.8M |
| Q4 25 | $1.2M | — | ||
| Q3 25 | $1.2M | — | ||
| Q2 25 | $14.2M | — | ||
| Q1 25 | $14.3M | — | ||
| Q4 24 | $14.4M | — | ||
| Q3 24 | $14.5M | — | ||
| Q2 24 | $14.7M | — | ||
| Q1 24 | $25.7M | — |
| Q4 25 | $509.8M | $-249.4M | ||
| Q3 25 | $485.3M | $-235.7M | ||
| Q2 25 | $503.2M | $-214.1M | ||
| Q1 25 | $517.4M | $-417.5M | ||
| Q4 24 | $534.1M | $-398.4M | ||
| Q3 24 | $542.6M | $-344.1M | ||
| Q2 24 | $556.4M | $-203.2M | ||
| Q1 24 | $575.0M | $371.6M |
| Q4 25 | $1.2B | $308.9M | ||
| Q3 25 | $1.3B | $362.6M | ||
| Q2 25 | $1.3B | $379.2M | ||
| Q1 25 | $1.3B | $405.1M | ||
| Q4 24 | $1.3B | $437.4M | ||
| Q3 24 | $1.2B | $537.8M | ||
| Q2 24 | $1.2B | $691.5M | ||
| Q1 24 | $1.3B | $1.3B |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | 0.03× | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | 0.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.6M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.6M | $8.2M | ||
| Q3 25 | $17.6M | $11.4M | ||
| Q2 25 | $22.1M | $-21.3M | ||
| Q1 25 | $12.3M | $8.5M | ||
| Q4 24 | $70.0M | $-14.7M | ||
| Q3 24 | $16.3M | $-9.4M | ||
| Q2 24 | $18.9M | $-11.9M | ||
| Q1 24 | $14.3M | $-621.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 37.84× | -0.11× | ||
| Q1 25 | 3.28× | — | ||
| Q4 24 | 23.83× | — | ||
| Q3 24 | 4.81× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 6.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
